177 related articles for article (PubMed ID: 34687740)
41. MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer.
Wolkersdörfer T; Füssel M; Kiesslich T; Neureiter D; Berr F; Aust D; Wolkersdörfer GW
Oncol Rep; 2011 Nov; 26(5):1165-71. PubMed ID: 21874254
[TBL] [Abstract][Full Text] [Related]
42. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
Menon AG; Janssen-van Rhijn CM; Morreau H; Putter H; Tollenaar RA; van de Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2004 Apr; 84(4):493-501. PubMed ID: 14968119
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of loss of HLA class I expression on colorectal tumor cells.
Browning M; Petronzelli F; Bicknell D; Krausa P; Rowan A; Tonks S; Murray N; Bodmer J; Bodmer W
Tissue Antigens; 1996 May; 47(5):364-71. PubMed ID: 8795136
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
45. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
46. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
47. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
Menon AG; Morreau H; Tollenaar RA; Alphenaar E; Van Puijenbroek M; Putter H; Janssen-Van Rhijn CM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2002 Dec; 82(12):1725-33. PubMed ID: 12480922
[TBL] [Abstract][Full Text] [Related]
49. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.
Kim JH; Kang GH
World J Gastroenterol; 2014 Apr; 20(15):4230-43. PubMed ID: 24764661
[TBL] [Abstract][Full Text] [Related]
50. Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability.
An CH; Kim YR; Kim HS; Kim SS; Yoo NJ; Lee SH
Hum Pathol; 2012 Jan; 43(1):40-7. PubMed ID: 21733561
[TBL] [Abstract][Full Text] [Related]
51. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
[TBL] [Abstract][Full Text] [Related]
52. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
[TBL] [Abstract][Full Text] [Related]
53. HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
Bossard C; Bézieau S; Matysiak-Budnik T; Volteau C; Laboisse CL; Jotereau F; Mosnier JF
Int J Cancer; 2012 Aug; 131(4):855-63. PubMed ID: 21953582
[TBL] [Abstract][Full Text] [Related]
54. Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang YH; Chen KH; Tsai JH; Cheng YM; Lee CC; Kao CH; Chan KY; Chen YT; Hsu WL; Yeh KH
J Biomed Sci; 2021 Nov; 28(1):75. PubMed ID: 34758826
[TBL] [Abstract][Full Text] [Related]
55. Immune evasion of microsatellite unstable colorectal cancers.
Kloor M; Michel S; von Knebel Doeberitz M
Int J Cancer; 2010 Sep; 127(5):1001-10. PubMed ID: 20198617
[TBL] [Abstract][Full Text] [Related]
56. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
57. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer.
Zhu X; Fang H; Gladysz K; Barbour JA; Wong JWH
Eur J Cancer; 2021 Nov; 157():94-107. PubMed ID: 34492588
[TBL] [Abstract][Full Text] [Related]
59. Frameshift mutations of poly(adenosine diphosphate-ribose) polymerase genes in gastric and colorectal cancers with microsatellite instability.
Kim MS; An CH; Kim SS; Yoo NJ; Lee SH
Hum Pathol; 2011 Sep; 42(9):1289-96. PubMed ID: 21333322
[TBL] [Abstract][Full Text] [Related]
60. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
Li WQ; Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Iacopetta B
Mol Cancer; 2006 Jan; 5():2. PubMed ID: 16403224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]